Edition:
United Kingdom

Arbutus Biopharma Corp (ABUS.OQ)

ABUS.OQ on NASDAQ Stock Exchange Global Select Market

9.45USD
19 Sep 2018
Change (% chg)

$-0.10 (-1.05%)
Prev Close
$9.55
Open
$9.55
Day's High
$9.60
Day's Low
$9.35
Volume
18,689
Avg. Vol
120,390
52-wk High
$12.50
52-wk Low
$4.30

Chart for

About

Arbutus Biopharma Corp is a Canada-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). The Company develops a portfolio of drug candidates with multiple... (more)
No analyst recommendations are available for .

Overall

Beta: 0.72
Market Cap(Mil.): $493.14
Shares Outstanding(Mil.): 55.03
Dividend: --
Yield (%): --

Financials

  ABUS.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -2.15 -- --
ROI: -51.57 15.07 14.61
ROE: -55.72 16.59 16.33

Earnings vs. Estimates